How should a patent foramen ovale (PFO) be further evaluated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Further Evaluate a Patent Foramen Ovale (PFO)

For patients with suspected PFO, particularly in the context of cryptogenic stroke, begin with transesophageal echocardiography (TEE) with bubble contrast and Valsalva maneuver as the gold standard diagnostic test, supplemented by transcranial Doppler (TCD) for initial screening and shunt quantification. 1, 2

Diagnostic Algorithm

Initial Screening

  • Transcranial Doppler (TCD) with bubble contrast should be your first-line screening tool
    • Highest sensitivity (98% detection rate with Valsalva maneuver) 3
    • Non-invasive and well-tolerated
    • Excellent for detecting right-to-left shunt 1
    • Perform at rest and with Valsalva maneuver to increase sensitivity 2

Confirmatory Testing

  • Transesophageal echocardiography (TEE) with bubble contrast is essential for:
    • Direct visualization of the PFO anatomy 2, 4
    • Measuring PFO dimensions (entrance and exit diameter) 3
    • Identifying high-risk features:
      • Atrial septal aneurysm (excessive bulging of fossa ovalis) 2
      • Large tunnel length
      • Prominent Eustachian valve 5
    • Ruling out alternative embolic sources (atrial thrombi, cardiac tumors, valve vegetations) 2
    • Mandatory before any planned PFO closure 2

Complementary Testing

  • Transthoracic echocardiography (TTE) with bubble contrast:
    • Less sensitive than TEE (89% vs 96% detection) 3
    • Useful for quantifying shunt severity 3
    • May underestimate shunt size in 44% of patients compared to TCD 3

Critical Evaluation Components

Shunt Characterization

You must document:

  • Shunt size: Small, moderate, or large based on bubble count in left atrium 3
  • PFO dimensions: Entrance and exit diameter (larger diameters correlate with severe shunts) 3
  • Timing of shunt: Early appearance (within 3-5 cardiac cycles) suggests PFO vs delayed suggests pulmonary shunt 4

High-Risk Anatomical Features

Look specifically for:

  • Atrial septal aneurysm (marker of increased embolic risk) 2
  • Large PFO tunnel (>10mm) 6
  • Prominent Eustachian valve or Chiari network 7

Context-Specific Evaluation

For Cryptogenic Stroke Patients

Before attributing stroke to PFO, you must exclude other causes 2:

  • Prolonged cardiac monitoring (mobile telemetry or implantable loop recorder) to rule out atrial fibrillation 1
  • Vascular imaging: MRA or CTA of intracranial and extracranial vessels to exclude atherosclerosis, dissection, or vasculopathy 1
  • Hypercoagulability workup if clinically indicated 1
  • Risk stratification: Consider RoPE score (>8 suggests PFO-related stroke) 2

Optimal Testing Strategy

The most practical diagnostic approach combines all three modalities sequentially 3:

  1. First: TCD with bubble contrast for screening
  2. Second: TTE with bubble contrast to quantify shunt severity
  3. Third: TEE with bubble contrast to assess anatomy when closure is contemplated

Common Pitfalls to Avoid

  • Don't rely on TTE alone: It has lower sensitivity than TCD and may miss significant shunts 3
  • Don't skip Valsalva maneuver: Sensitivity increases dramatically from 43-61% at rest to 89-98% with Valsalva 3
  • Don't confuse PFO with atrial septal defect: TEE directly visualizes the anatomy to differentiate 4
  • Don't assume all PFOs are clinically significant: Only large shunts (typically ≥10mm) with high-risk features are associated with paradoxical embolism 6

Age and Risk Factor Considerations

These recommendations apply primarily to patients under 60 years old 2. In older patients or those with traditional vascular risk factors (diabetes, hypertension, hyperlipidemia), fewer cryptogenic strokes are caused by paradoxical embolism, making PFO less likely to be the culprit 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.